General Practice Actions for The Safe Use of Topiramate in NEL
Posted on:
Topiramate is used in some patients for the treatment for epilepsy, other seizure disorders, and migraine. Exposure to topiramate in pregnancy is associated with significant harm to the unborn child, such as an increased risk of congenital malformations, autism spectrum disorders, intellectual disability, and neurodevelopmental disorders.
Due to the accumulation of evidence of these harms, MHRA has issued new safety measures
to further support prescribers around the safe use of topiramate in all women of childbearing potential and in pregnancy,
Please follow this link to download this notification in full.